In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.

Benzer Materyaller

• In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
  Yazar:: Kaatz, G W, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
  Yazar:: Jorgensen, J H, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
  Yazar:: Zurenko, G E, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.
  Yazar:: Jones, R N, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
  Yazar:: Mason, E O, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)